Header Logo

Connection

Bette Caan to Colonic Neoplasms

Back to Details
This is a "connection" page, showing publications Bette Caan has written about Colonic Neoplasms.
Bette Caan
Connection Strength
7.394
Colonic Neoplasms
  1. The association of abdominal adiposity with premature discontinuation of postoperative chemotherapy in colon cancer. Clin Nutr. 2022 Jul; 41(7):1600-1604.
    View in: PubMed
    Score: 0.757
  2. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 2017 Dec 15; 123(24):4868-4877.
    View in: PubMed
    Score: 0.546
  3. Genetic variation in the transforming growth factor-ß-signaling pathway, lifestyle factors, and risk of colon or rectal cancer. Dis Colon Rectum. 2012 May; 55(5):532-40.
    View in: PubMed
    Score: 0.377
  4. Genetic variation in the transforming growth factor-ß signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer. 2011 Sep 15; 117(18):4175-83.
    View in: PubMed
    Score: 0.348
  5. Effect of resistance training on physical function during chemotherapy in colon cancer. JNCI Cancer Spectr. 2024 Jul 01; 8(4).
    View in: PubMed
    Score: 0.219
  6. Low-energy reporters: evaluation of potential differential reporting in case-control studies. Nutr Cancer. 2002; 42(2):173-9.
    View in: PubMed
    Score: 0.184
  7. Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery. JAMA Surg. 2020 10 01; 155(10):942-949.
    View in: PubMed
    Score: 0.169
  8. Lifestyle and colon cancer: an assessment of factors associated with risk. Am J Epidemiol. 1999 Oct 15; 150(8):869-77.
    View in: PubMed
    Score: 0.158
  9. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. Int J Cancer. 2020 01 15; 146(2):363-372.
    View in: PubMed
    Score: 0.155
  10. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord. 1998 Feb; 22(2):178-84.
    View in: PubMed
    Score: 0.140
  11. Vitamin E and colon cancer: is there an association? Nutr Cancer. 1998; 30(3):201-6.
    View in: PubMed
    Score: 0.140
  12. Diet diversity, diet composition, and risk of colon cancer (United States). Cancer Causes Control. 1997 Nov; 8(6):872-82.
    View in: PubMed
    Score: 0.138
  13. Plant foods and colon cancer: an assessment of specific foods and their related nutrients (United States). Cancer Causes Control. 1997 Jul; 8(4):575-90.
    View in: PubMed
    Score: 0.135
  14. The Optimal Body Mass Index Range for Patients With Colorectal Cancer-Reply. JAMA Oncol. 2017 05 01; 3(5):708.
    View in: PubMed
    Score: 0.133
  15. A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.117
  16. The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the Women's Health Initiative. Cancer Causes Control. 2015 Mar; 26(3):399-408.
    View in: PubMed
    Score: 0.113
  17. An analysis of genetic factors related to risk of inflammatory bowel disease and colon cancer. Cancer Epidemiol. 2014 Oct; 38(5):583-90.
    View in: PubMed
    Score: 0.110
  18. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013 Dec; 24(12):2059-75.
    View in: PubMed
    Score: 0.105
  19. Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res. 2013 Apr; 57(4):721-34.
    View in: PubMed
    Score: 0.097
  20. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer. 2012 Jun; 51(6):598-605.
    View in: PubMed
    Score: 0.093
  21. Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer. 2012 Feb 01; 130(3):653-64.
    View in: PubMed
    Score: 0.088
  22. Variation in the CYP19A1 gene and risk of colon and rectal cancer. Cancer Causes Control. 2011 Jul; 22(7):955-63.
    View in: PubMed
    Score: 0.088
  23. Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer. 2010 Dec 04; 10:670.
    View in: PubMed
    Score: 0.085
  24. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
    View in: PubMed
    Score: 0.085
  25. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-ß-signaling pathway. Carcinogenesis. 2011 Mar; 32(3):318-26.
    View in: PubMed
    Score: 0.085
  26. Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res. 2010 Feb 15; 70(4):1479-85.
    View in: PubMed
    Score: 0.081
  27. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3384-8.
    View in: PubMed
    Score: 0.080
  28. MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog. 2009 Nov; 48(11):989-94.
    View in: PubMed
    Score: 0.079
  29. Vitamin D related genes, CYP24A1 and CYP27B1, and colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Sep; 18(9):2540-8.
    View in: PubMed
    Score: 0.078
  30. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009 Jul; 52(7):1304-11.
    View in: PubMed
    Score: 0.077
  31. Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer. 2009 Jan; 48(1):1-9.
    View in: PubMed
    Score: 0.075
  32. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res. 2009 Jan 15; 660(1-2):12-21.
    View in: PubMed
    Score: 0.074
  33. The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer. 2008 Oct; 47(10):835-44.
    View in: PubMed
    Score: 0.074
  34. Genetic variation in calcium-sensing receptor and risk for colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2755-65.
    View in: PubMed
    Score: 0.074
  35. Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut. 2009 May; 58(5):661-7.
    View in: PubMed
    Score: 0.072
  36. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer. 2008 Apr 01; 122(7):1611-7.
    View in: PubMed
    Score: 0.071
  37. Transcription factor 7-like 2 polymorphism and colon cancer. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):978-82.
    View in: PubMed
    Score: 0.071
  38. IL6 genotypes and colon and rectal cancer. Cancer Causes Control. 2007 Dec; 18(10):1095-105.
    View in: PubMed
    Score: 0.068
  39. Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer. 2007 May 15; 120(10):2226-32.
    View in: PubMed
    Score: 0.067
  40. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst. 2006 Dec 06; 98(23):1731-8.
    View in: PubMed
    Score: 0.065
  41. Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Mutat Res. 2006 Mar 20; 595(1-2):117-24.
    View in: PubMed
    Score: 0.062
  42. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer. 2006; 55(1):35-43.
    View in: PubMed
    Score: 0.061
  43. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 Dec; 14(12):2936-42.
    View in: PubMed
    Score: 0.060
  44. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2005 Nov; 14(11 Pt 1):2509-16.
    View in: PubMed
    Score: 0.060
  45. MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr. 2005 Oct; 135(10):2462-7.
    View in: PubMed
    Score: 0.060
  46. Energy balance, insulin-related genes and risk of colon and rectal cancer. Int J Cancer. 2005 May 20; 115(1):148-54.
    View in: PubMed
    Score: 0.058
  47. Interactions of peroxisome proliferator-activated receptor {gamma} and diet in etiology of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1224-9.
    View in: PubMed
    Score: 0.058
  48. Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1350-2.
    View in: PubMed
    Score: 0.058
  49. The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr. 2005 Feb; 135(2):179-86.
    View in: PubMed
    Score: 0.057
  50. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr. 2005 Feb; 135(2):252-9.
    View in: PubMed
    Score: 0.057
  51. PPARgamma, energy balance, and associations with colon and rectal cancer. Nutr Cancer. 2005; 51(2):155-61.
    View in: PubMed
    Score: 0.057
  52. Carotenoids, vitamin A and risk of adenomatous polyp recurrence in the polyp prevention trial. Int J Cancer. 2004 Nov 01; 112(2):295-305.
    View in: PubMed
    Score: 0.056
  53. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control. 2004 Nov; 15(9):863-72.
    View in: PubMed
    Score: 0.056
  54. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2004 Feb; 13(2):285-92.
    View in: PubMed
    Score: 0.053
  55. Sex-specific differences in colon cancer associated with p53 mutations. Nutr Cancer. 2004; 49(1):41-8.
    View in: PubMed
    Score: 0.053
  56. Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control. 2003 Feb; 14(1):75-84.
    View in: PubMed
    Score: 0.050
  57. Adenomatous polyp recurrence and physical activity in the Polyp Prevention Trial (United States). Cancer Causes Control. 2002 Jun; 13(5):445-53.
    View in: PubMed
    Score: 0.047
  58. Eating frequency and the risk of colon cancer. Nutr Cancer. 2002; 43(2):121-6.
    View in: PubMed
    Score: 0.046
  59. Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer. Int J Cancer. 2000 Sep 01; 87(5):728-33.
    View in: PubMed
    Score: 0.042
  60. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control. 2000 May; 11(5):459-66.
    View in: PubMed
    Score: 0.041
  61. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes Control. 2000 Jan; 11(1):1-8.
    View in: PubMed
    Score: 0.040
  62. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control. 1999 Oct; 10(5):467-73.
    View in: PubMed
    Score: 0.039
  63. Intake of fluids and methylxanthine-containing beverages: association with colon cancer. Int J Cancer. 1999 Apr 12; 81(2):199-204.
    View in: PubMed
    Score: 0.038
  64. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. Cancer Epidemiol Biomarkers Prev. 1999 Jan; 8(1):15-24.
    View in: PubMed
    Score: 0.037
  65. Comparison of the Block and the Willett self-administered semiquantitative food frequency questionnaires with an interviewer-administered dietary history. Am J Epidemiol. 1998 Dec 15; 148(12):1137-47.
    View in: PubMed
    Score: 0.037
  66. NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1998 Dec; 7(12):1079-84.
    View in: PubMed
    Score: 0.037
  67. Risk of colon cancer associated with a family history of cancer or colorectal polyps: the diet, activity, and reproduction in colon cancer study. Int J Cancer. 1998 Oct 05; 78(2):157-60.
    View in: PubMed
    Score: 0.037
  68. Eating patterns and risk of colon cancer. Am J Epidemiol. 1998 Jul 01; 148(1):4-16.
    View in: PubMed
    Score: 0.036
  69. Performance of a shortened telephone-administered version of a quantitative food frequency questionnaire. Ann Epidemiol. 1997 Oct; 7(7):463-71.
    View in: PubMed
    Score: 0.034
  70. Dietary sugar and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):677-85.
    View in: PubMed
    Score: 0.034
  71. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 1997 Mar; 8(2):146-58.
    View in: PubMed
    Score: 0.033
  72. Dietary energy sources and colon cancer risk. Am J Epidemiol. 1997 Feb 01; 145(3):199-210.
    View in: PubMed
    Score: 0.033
  73. Energy balance and colon cancer--beyond physical activity. Cancer Res. 1997 Jan 01; 57(1):75-80.
    View in: PubMed
    Score: 0.033
  74. A description of age, sex, and site distributions of colon carcinoma in three geographic areas. Cancer. 1996 Oct 15; 78(8):1666-70.
    View in: PubMed
    Score: 0.032
  75. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb; 19(1):61-109.
    View in: PubMed
    Score: 0.018
  76. Response rates among control subjects in case-control studies. Ann Epidemiol. 1995 May; 5(3):245-9.
    View in: PubMed
    Score: 0.007
  77. A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc. 1994 Jul; 94(7):761-6.
    View in: PubMed
    Score: 0.007

© 2024 Kaiser Permanente